GSK-115373

Study Sponsor: GSK

Study Title

Safety and immunogenicity study of GSK Biologicals’ pneumococcal vaccine 2830930A when administered as a single dose in healthy toddlers aged 12-23 months

Medicine or Vaccine (generic name)

12-valent pneumococcal polysaccharide and non-typeable Haemophilus influenzae protein D conjugate vaccine

Sponsor Identification Number

115373

Trial Registry Identification Number(#'s)

NCT01485406 2011-002225-22

Medical Condition

Infections, Streptococcal

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=115373

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01485406

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2011-002225-22

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

January 2021